GlassScriptPhysician profile
Jennifer Train
NPI 1225467509
$939.76
in general payments reported to CMS, 2019-2025
22 companies · $238 in 2025
The $238 reported for 2025 was more than what 79% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $146 · 2023: $177 · 2024: $263 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $145.71 | 2023-2025 | |
| Glaxosmithkline, LLC. | $128.37 | 2023-2024 | Bexsero, Rotarix, Pediarix |
| Sanofi-Aventis U.S. LLC | $70.43 | 2024-2025 | |
| Alk-Abello, INC | $68.73 | 2023-2025 | Ragwitek, Grastek, Neffy |
| Cranial Technologies, INC | $56.40 | 2022-2024 | Doc Band |
| Sanofi Pasteur INC. | $56.19 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.34 | 2021-2024 | Vaxelis, Gardasil 9, Gardasil |
| Tris Pharma INC | $44.86 | 2021-2022 | |
| Kaleo, INC. | $38.22 | 2022-2023 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $37.93 | 2025 | Jornay Pm |
| Sobi, INC | $32.37 | 2022-2024 | |
| Biogen, INC. | $30.50 | 2024 | Spinraza |
| Takeda Pharmaceuticals U.S.A., INC. | $30.36 | 2021-2022 | |
| Krystal Biotech INC | $20.20 | 2025 | Vyjuvek |
| Seqirus USA INC | $18.23 | 2024 | Flucelvax |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $17.10 | 2023 | Azstarys |
| Phadia US INC. | $16.05 | 2021 | |
| Adlon Therapeutics L.P. | $16.03 | 2021 | |
| Biomerieux INC | $15.46 | 2025 | Biofire Spotfire Control Station |
| Cognoa, INC. | $14.68 | 2022 | |
| Aimmune Therapeutics, INC. | $14.55 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.05 | 2024 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Train listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.